CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

Introduction: Treating autoimmune diseases without nonspecific immunosuppression remains challenging. To prevent or treat these conditions through targeted immunotherapy, we developed a clinical-stage ...

Correspondence to Dr Noel F C C de Miranda, Pathology, Leiden University Medical Center, Leiden, The Netherlands; N.F.de_Miranda{at}lumc.nl Objective A comprehensive understanding of anticancer immune ...

Among the many abnormalities in the liver, hepatic fibrosis is one of the most common liver diseases in many developed countries (1–4). The disease occurs in response to chronic liver injury and is ...

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

AT&T remains on track to achieve its net leverage target of net-debt-to-adjusted EBITDA in the 2.5x range by the first half of 2025 and intends to sustain this level through 2027.

Macrophages control intracellular pathogens like Salmonella by using two caspase enzymes at different times during infection.

Lymphocytes are white blood cells that help the body fight infection and disease. The healthy range for an adult is between 1,000 and 4,800 lymphocytes per microliter (µL) of blood. Doctors will ...

Researchers have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. Scientists have supercharged CAR-T therapy, making it more powerful ...